Datelliptium chloride hydrochloride
Code | Size | Price |
---|
TAR-T7747-1mg | 1mg | £650.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7747-5mg | 5mg | £1,340.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7747-10mg | 10mg | £1,910.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7747-25mg | 25mg | £3,259.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7747-50mg | 50mg | £5,348.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7747-100mg | 100mg | £8,022.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Datelliptium chloride hydrochloride is a DNA-intercalating agent derived from ellipticine. with anti-tumor activities.
CAS:
157000-76-5
Formula:
C23H29Cl2N3O
Molecular Weight:
434.41
Pathway:
DNA Damage/DNA Repair; Cell Cycle/Checkpoint
Purity:
0.9991
SMILES:
Cl.[Cl-].CCN(CC)CC[n+]1ccc2c(C)c3[nH]c4ccc(O)cc4c3c(C)c2c1
Target:
DNA/RNA Synthesis
References
Mucci-Lorusso P , Polin L , Biernat L A , et al. Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice[J]. Investigational New Drugs, 1990, 8(3):253-261.
Khayat D , Borel C , Azab M , et al. Phase I study of Datelliptium chloride, hydrochloride given by 24-h continuous intravenous infusion[J]. Cancer Chemotherapy and Pharmacology, 1992, 30(3):226-228.